Purdue Pharma and Sackler Family Settlement Talks Extended Until November
Purdue Pharma and Sackler Family Settlement Talks Extended Until November

Latest News

Purdue Pharma has received an extension until November 1 for settlement talks with the Sackler family, who own the company, allowing them to continue avoiding civil lawsuits linked to the opioid crisis. This extension follows a Chapter 11 filing in 2019 and succeeds multiple previous extensions due to legal complications, including a recent Supreme Court decision that voided a proposed $6 billion settlement. While many creditors and a committee representing opioid victims support the extension, some states, such as Rhode Island and Washington, oppose it, arguing that it has allowed Sackler family members to evade accountability for years. The outcome of the ongoing mediation remains uncertain, though significant progress has been reported by Purdue’s legal representatives.

Source and details of the news

Related News